Brief: Alzchem Group AG - €120 Million Investment In New Automated Creatine Facility
Dec 4 (Reuters) - Alzchem Group AG ACT1.DE: ALZCHEM GROUP AG - €120 MILLION INVESTMENT IN NEW AUTOMATED CREATINE FACILITY ALZCHEM GROUP AG - COMMISSIONING PLANNED FROM SECOND HALF OF 2027 ALZCHEM GROUP AG - ALZCHEM SEES THIS INVESTMENT AS OFFERING ADDITIONAL ANNUAL SALES POTENTIAL IN LOW TRIPLE-DIGIT MILLION EURO RANGE Source text: ID:nEQbJxh8Ja Further company coverage: ACT1.DE (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))
Recent news on AlzChem AG
See all newsGermany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group
Creamino Is Now Approved In EU For Use In Turkey Nutrition
Germany's Alzchem Group Q1 EBITDA, sales rise on specialty chemicals focus
Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth